There are 2789 resources available
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display
106P - Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis
Presenter: Yao Jin
Session: ePoster Display
107P - Co-mutation of IDH1 and DNA damage repair genes in patients with hepatobiliary cancer implicates longer overall survival
Presenter: Guangming Li
Session: ePoster Display
452P - Predicting response to bevacizumab in colorectal cancer by integrating radiomics to clinical and genomic features
Presenter: Gianluca Milanese
Session: ePoster Display
453P - Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centre
Presenter: David Lau
Session: ePoster Display
454P - CCR5/CCL5 gene expression in colorectal cancer (CRC): Comprehensive profiling and clinical value
Presenter: Francesca Battaglin
Session: ePoster Display
455P - Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Presenter: Manuel Valladares-Ayerbes
Session: ePoster Display
456P - Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer
Presenter: Safa Can Efil
Session: ePoster Display